Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Dvx 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ishjas Pharma Pvt Ltd

Salt Composition

Divalproex (750mg)

Overview Dvx 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release 750mg Dvx tablet. It can also be employed, in some cases, as a treatment for bipolar disorder, either independently or as part of a broader medication regimen. Dosage and frequency are determined by your physician to optimize symptom control. Administer this medication at the same time daily, with or without food, for maximum effectiveness; therapeutic benefits usually manifest within two weeks. Consistent use, as directed, is vital, even during symptom remission, as discontinuation or missed doses can exacerbate the underlying condition and potentially trigger seizures; abrupt cessation is strictly contraindicated. Commonly reported side effects include nausea, vomiting, dizziness, fatigue, visual disturbances, headache, ataxia, easy bruising, and hypothermia. While typically mild, persistent or bothersome side effects warrant medical attention. Immediately report any skin rash or redness. Prolonged use may decrease bone density (osteoporosis), elevating fracture risk. Suicidal ideation or behavior is a rare but serious potential adverse effect; report any mood changes to your doctor immediately. Prior to commencing treatment, inform your physician of any history of liver or kidney impairment, urinary difficulties, cardiac disease, depression, or suicidal tendencies; this medication may not be appropriate for everyone. Numerous drug interactions are possible, so disclose all current medications to ensure safety and efficacy. Pregnant individuals should consult their physician before initiating or discontinuing this medication. Alcohol consumption should be avoided due to the risk of intensified side effects and increased seizure susceptibility. Regular blood monitoring, pre- and post-treatment, is often necessary for optimal dose adjustment.

Uses of Dvx 750mg Tablet ER

Managing epileptic seizures and bipolar disorder; migraine prophylaxis.

Major Benefits of Dvx 750mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 750mg extended-release Dvx tablet whole; do not crush, chew, or divide it. While food is optional, consistent timing is recommended.

Common Side effects of Dvx 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Dvx 750mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 750mg extended-release Dvx tablet whole; avoid chewing, crushing, or fracturing. While consumption with or without food is permissible, consistent timing is recommended for optimal results.

How Dvx 750mg Tablet ER works:

Extended-release Dvx 750mg tablets are used to manage epilepsy. This anticonvulsant medication works by reducing the hyperactivity of neurons in the brain, thus preventing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Dvx 750mg extended-release tablets and alcohol can lead to significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Dvx 750mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Dvx 750mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known threat to the infant.

DrivingDrivingUNSAFE

Extended-release Dvx 750mg tablets can induce adverse reactions that may impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Dvx 750mg tablets pose no safety concerns for patients with renal impairment; no dosage alteration is necessary.

LiverLiverUNSAFE

Extended-release Dvx 750mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Dvx 750mg Tablet ER :

Should you forget to take a Dvx 750mg Extended-Release tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Dvx 750mg Tablet ER

LabelValue
Chemical Category Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Central Nervous System (CNS) Neurology
Action Class Antiepileptic drugs that modulate sodium channels

FAQs on Dvx 750mg Tablet ER

Always consult your doctor before discontinuing Dvx 750mg Tablet ER. Withdrawal should be gradual, under medical supervision, to avoid potential side effects such as symptom recurrence, irritability, anxiety, dizziness, and tremors.
Dvx 750mg Extended-Release tablets can be used to stabilize mood in patients experiencing rapid mood swings. This effect is achieved by reducing excessive brain activity associated with these mood changes.
Weight gain is a possible side effect of Dvx 750mg Tablet ER, potentially stemming from increased appetite. To minimize this risk, maintain a healthy diet and exercise regularly. Consult your doctor if weight gain is a concern.
Dvx 750mg Tablet ER can cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, temporary side effect of Dvx 750mg Tablet ER, often linked to dosage. Consult your doctor if this occurs or continues.
Dvx 750mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver problems. Baseline liver function tests are recommended before starting Dvx 750mg Tablet ER, with regular testing during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol while taking Dvx 750mg Tablet ER. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Dvx 750mg Tablet ER, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation studies to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and during the first six months of treatment, particularly for patients with pre-existing liver conditions or other risk factors.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result necessitates immediate medication cessation.
Dvx 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and drowsiness. Further symptoms may include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Dvx 750mg Tablet ER
151
MRP 175
13% off